128 related articles for article (PubMed ID: 37315771)
1. Ribotoxin deoxynivalenol induces taurocholic acid malabsorption in an in vitro human intestinal model.
Wang J; Sijs B; Bakker W; de Haan L; Bouwmeester H
Toxicol Lett; 2023 Jul; 383():54-63. PubMed ID: 37315771
[TBL] [Abstract][Full Text] [Related]
2. Exposure to the mycotoxin deoxynivalenol reduces the transport of conjugated bile acids by intestinal Caco-2 cells.
Wang J; Bakker W; Zheng W; de Haan L; Rietjens IMCM; Bouwmeester H
Arch Toxicol; 2022 May; 96(5):1473-1482. PubMed ID: 35224661
[TBL] [Abstract][Full Text] [Related]
3. Deoxynivalenol increases pro-inflammatory cytokine secretion and reduces primary bile acid transport in an inflamed intestinal in vitro co-culture model.
Wang J; Bakker W; de Haan L; Bouwmeester H
Food Res Int; 2023 Nov; 173(Pt 1):113323. PubMed ID: 37803634
[TBL] [Abstract][Full Text] [Related]
4. p38 Mitogen-activated protein kinase mediates IL-8 induction by the ribotoxin deoxynivalenol in human monocytes.
Islam Z; Gray JS; Pestka JJ
Toxicol Appl Pharmacol; 2006 Jun; 213(3):235-44. PubMed ID: 16364386
[TBL] [Abstract][Full Text] [Related]
5. Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck.
Zhou HR; Jia Q; Pestka JJ
Toxicol Sci; 2005 Jun; 85(2):916-26. PubMed ID: 15772366
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for ribotoxin-induced ribosomal RNA cleavage.
He K; Zhou HR; Pestka JJ
Toxicol Appl Pharmacol; 2012 Nov; 265(1):10-8. PubMed ID: 23022514
[TBL] [Abstract][Full Text] [Related]
7. Modulation of early growth response gene 1 and interleukin-8 expression by ribotoxin deoxynivalenol (vomitoxin) via ERK1/2 in human epithelial intestine 407 cells.
Moon Y; Yang H; Lee SH
Biochem Biophys Res Commun; 2007 Oct; 362(2):256-62. PubMed ID: 17707346
[TBL] [Abstract][Full Text] [Related]
8. The Food-Associated Ribotoxin Deoxynivalenol Modulates Inducible NO Synthase in Human Intestinal Cell Model.
Graziani F; Pujol A; Nicoletti C; Pinton P; Armand L; Di Pasquale E; Oswald IP; Perrier J; Maresca M
Toxicol Sci; 2015 Jun; 145(2):372-82. PubMed ID: 25766886
[TBL] [Abstract][Full Text] [Related]
9. Intestinal toxicity of the masked mycotoxin deoxynivalenol-3-β-D-glucoside.
Pierron A; Mimoun S; Murate LS; Loiseau N; Lippi Y; Bracarense AP; Liaubet L; Schatzmayr G; Berthiller F; Moll WD; Oswald IP
Arch Toxicol; 2016 Aug; 90(8):2037-46. PubMed ID: 26404761
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-alpha expression by deoxynivalenol (vomitoxin).
Chung YJ; Zhou HR; Pestka JJ
Toxicol Appl Pharmacol; 2003 Dec; 193(2):188-201. PubMed ID: 14644621
[TBL] [Abstract][Full Text] [Related]
11. Deoxynivalenol-induced mitogen-activated protein kinase phosphorylation and IL-6 expression in mice suppressed by fish oil.
Moon Y; Pestka JJ
J Nutr Biochem; 2003 Dec; 14(12):717-26. PubMed ID: 14690764
[TBL] [Abstract][Full Text] [Related]
12. Double-stranded RNA-activated protein kinase mediates induction of interleukin-8 expression by deoxynivalenol, Shiga toxin 1, and ricin in monocytes.
Gray JS; Bae HK; Li JC; Lau AS; Pestka JJ
Toxicol Sci; 2008 Oct; 105(2):322-30. PubMed ID: 18599499
[TBL] [Abstract][Full Text] [Related]
13. Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependent mechanism.
Pinton P; Braicu C; Nougayrede JP; Laffitte J; Taranu I; Oswald IP
J Nutr; 2010 Nov; 140(11):1956-62. PubMed ID: 20861219
[TBL] [Abstract][Full Text] [Related]
14. Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenol-induced ribotoxic stress response.
Zhou HR; Lau AS; Pestka JJ
Toxicol Sci; 2003 Aug; 74(2):335-44. PubMed ID: 12773753
[TBL] [Abstract][Full Text] [Related]
15. Influence of deoxynivalenol on NF-kappaB activation and IL-8 secretion in human intestinal Caco-2 cells.
Van De Walle J; Romier B; Larondelle Y; Schneider YJ
Toxicol Lett; 2008 Apr; 177(3):205-14. PubMed ID: 18343055
[TBL] [Abstract][Full Text] [Related]
16. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations.
Sergent T; Parys M; Garsou S; Pussemier L; Schneider YJ; Larondelle Y
Toxicol Lett; 2006 Jul; 164(2):167-76. PubMed ID: 16442754
[TBL] [Abstract][Full Text] [Related]
17. Modulation of inflammatory gene expression by the ribotoxin deoxynivalenol involves coordinate regulation of the transcriptome and translatome.
He K; Pan X; Zhou HR; Pestka JJ
Toxicol Sci; 2013 Jan; 131(1):153-63. PubMed ID: 22968694
[TBL] [Abstract][Full Text] [Related]
18. Impact of DUSP1 on the apoptotic potential of deoxynivalenol in the epithelial cell line HepG2.
Casteel M; Nielsen C; Kothlow S; Dietrich R; Märtlbauer E
Toxicol Lett; 2010 Nov; 199(1):43-50. PubMed ID: 20708668
[TBL] [Abstract][Full Text] [Related]
19. HuR/ELAVL1 RNA binding protein modulates interleukin-8 induction by muco-active ribotoxin deoxynivalenol.
Choi HJ; Yang H; Park SH; Moon Y
Toxicol Appl Pharmacol; 2009 Oct; 240(1):46-54. PubMed ID: 19591856
[TBL] [Abstract][Full Text] [Related]
20. Early phosphoproteomic changes in the mouse spleen during deoxynivalenol-induced ribotoxic stress.
Pan X; Whitten DA; Wu M; Chan C; Wilkerson CG; Pestka JJ
Toxicol Sci; 2013 Sep; 135(1):129-43. PubMed ID: 23811945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]